How peptides degrade: oxidation, deamidation and the chemistry behind storage rules
Oct
Peptides break down through a short list of known chemical routes: oxidation of methionine, cysteine and tryptophan, deamidation of asparagine and glutamine, cleavage of the peptide backbone, cyclization at the N-terminus, and aggregation. Each one needs water, oxygen, light or heat to move quickly.
Lyophilization slows these reactions by removing most of the water, but it does not stop them. That is why dry powder and solution behave so differently over time, and why storage rules are written the way they are.
This guide explains the chemistry behind peptide degradation and how each route shows up in laboratory analysis. It is the background to our practical piece on cold chain in transit and the first hour after a box arrives, and it explains several of the small peaks discussed in what a 99% purity number actually measures.
A peptide that degrades does not disappear. It turns into near relatives that sit beside the main peak and lower purity over time.
Why a stable-looking powder still changes
A dry cake looks inert, but chemistry continues inside it. Lai and Topp reviewed solid-state chemical stability of proteins and peptides and list the main reactions that still occur in dried formulations: deamidation, peptide bond cleavage, oxidation, the Maillard reaction, beta-elimination and dimerization or aggregation.
The same review names the factors that control how fast those reactions run:
- Temperature. Reaction rates rise with heat in the solid state as they do in solution.
- Moisture content. Residual or absorbed water gives molecules the mobility they need to react.
- Excipients. Other components in the cake can protect the peptide or react with it, as in the Maillard reaction with reducing sugars.
- Physical state. Amorphous and crystalline solids behave differently, and most lyophilized peptides are amorphous.
The main degradation routes
Each route targets particular residues or bonds, which is why two peptides of similar size can have very different stability. The table summarizes the routes most relevant to synthetic research peptides.
| Route | Residues or bonds most affected | What drives it | How it shows up in analysis |
|---|---|---|---|
| Oxidation | Methionine, cysteine, tryptophan, histidine | Oxygen, light, trace metals, peroxides | Mass increase of 16 Da per oxygen; new HPLC peaks, often eluting earlier |
| Deamidation | Asparagine, especially before glycine; glutamine more slowly | Water, neutral to basic pH, heat | Mass increase of about 1 Da; peaks very close to the main peak |
| Backbone cleavage | Bonds next to aspartic acid, such as Asp-Pro and Asp-Gly | Water, acidic conditions, heat | Shorter fragments with lower masses |
| Pyroglutamate formation | N-terminal glutamine or glutamic acid | Water, heat | Mass loss of 17 Da from glutamine or 18 Da from glutamic acid |
| Aggregation | Hydrophobic stretches, free cysteines | Concentration, surfaces, freeze-thaw cycles | Dimers and larger species; broadened or late peaks |
D’Hondt and colleagues group these as degradation-related impurities in their review of peptide medicines, listing beta-elimination, diketopiperazine, pyroglutamate and succinimide formation, separate from the impurities that come from synthesis itself.
Deamidation, the reaction that hides next to the main peak
Asparagine is the residue most prone to spontaneous change. The side chain attacks the backbone to form a five-membered succinimide ring, which then opens with water to give a mixture of products.
Geiger and Clarke measured this in a model hexapeptide containing an Asn-Gly sequence and found a deamidation half-life of only 1.4 days at 37 °C and pH 7.4 in solution. The products were a mixture of normal aspartyl and isoaspartyl forms, in both L and D configurations, because the succinimide intermediate also racemized quickly.
- The neighbor matters. Replacing the glycine after asparagine with a bulkier leucine or proline slowed degradation 33 to 50 fold in the same study.
- Aspartic acid is slower but not immune. An aspartic acid residue in place of asparagine formed the succinimide 34 times more slowly.
- Isomers are the end product. Isoaspartyl and D-aspartyl forms have the same mass as each other, which makes them hard to tell apart.
Deamidation adds about 1 Da to a molecule that may weigh several thousand. An LC-MS identity result can still read as a match within its tolerance, and isoaspartyl products have exactly the same mass as the aspartyl form. Chromatographic separation of the related peaks, not the mass alone, is what shows deamidation has happened.
Oxidation and light
Methionine oxidizes to methionine sulfoxide, adding one oxygen atom. Cysteine can oxidize or form unintended disulfide bonds with another molecule, which leads to dimers. Tryptophan and histidine are sensitive to light-driven oxidation.
Oxidation needs an oxidant, so it is driven by air in the vial headspace, dissolved oxygen in solution, trace metal ions and peroxides that some materials carry. Light speeds several of these reactions. That is the reason peptide storage guidance keeps vials sealed, dark and cold.
Water, the variable behind most of them
Deamidation, hydrolysis and pyroglutamate formation all use water as a reactant, and every route speeds up when molecules can move freely. Removing water is the single biggest stabilizing step in making a peptide powder.
Manning and colleagues’ update on protein pharmaceutical stability treats stabilization in aqueous solution and in the dried state as separate problems, and Wang’s review of liquid protein formulations describes the many routes that operate once a molecule is in solution. Peptides follow the same principles.
Dry powder
Low water content and limited molecular mobility. Reactions are slow, so the main risks are heat and moisture taken up from the air.
Moisture uptake
Lyophilized cakes absorb water readily. A cold vial opened before it reaches room temperature collects condensation, which raises water content in the cake.
Solution
Water is present in excess and molecules move freely. Deamidation, hydrolysis and aggregation all run much faster than in the dry state, which is why laboratories generally prepare solutions close to when they are needed.
Freeze-thaw
Each cycle concentrates the peptide and solutes in pockets of unfrozen liquid and exposes molecules to ice surfaces, both of which can promote aggregation.
How degradation shows up on a certificate
A certificate records a batch at one point in time. Degradation appears in later testing as a falling purity figure and new or growing related peaks in the chromatogram.
The features that make degradation visible on paper:
- A chromatogram, not just a number. Small peaks beside the main peak are where deamidation and oxidation products appear.
- A test date. It anchors the result. A certificate from long before a batch was made, or reused across batches, cannot show the current state of the material.
- An LC-MS result with masses. Shifts of plus 16 Da or minus 17 Da in minor peaks point to oxidation or pyroglutamate formation.
Conditions that speed degradation in a laboratory setting:
- Storage above the stated temperature for long periods
- Opening a cold vial before it reaches room temperature
- Repeated freeze-thaw cycles of the same solution
- Exposure to direct light
- Solutions held for long periods instead of prepared fresh
- Vials left unsealed or with damaged stoppers
Each lot we supply has its batch documents in our certificate library. If a vial arrives in a condition you are unsure about, contact the team with the batch number.
- Peptides degrade by oxidation, deamidation, backbone cleavage, cyclization and aggregation
- Each route targets particular residues, so stability depends on the sequence
- Lyophilization slows these reactions by removing water but does not stop them
- Deamidation adds about 1 Da and is seen in chromatography, not by mass alone
- Heat, moisture, light, oxygen and freeze-thaw cycles all speed degradation
- Degradation shows up as falling purity and new peaks in later testing
Frequently asked questions
Yes, slowly. Reactions such as deamidation, oxidation, peptide bond cleavage and aggregation still occur in the solid state. Their rate depends on temperature, moisture content, excipients and the physical state of the cake.
Asparagine, especially when followed by glycine, is the most prone to deamidation. Methionine, cysteine and tryptophan are the most prone to oxidation. Aspartic acid makes nearby peptide bonds easier to cleave, and N-terminal glutamine can cyclize to pyroglutamate.
A reaction in which the side-chain amide of asparagine or glutamine is lost, usually through a succinimide intermediate. It converts asparagine into a mixture of aspartyl and isoaspartyl forms and adds about 1 Da to the molecule’s mass.
Water is a reactant in deamidation, hydrolysis and pyroglutamate formation, and molecules move freely in solution, so every route runs faster. Dry powder has little water and limited mobility, which slows these reactions considerably.
By testing it again. RP-HPLC shows a lower main peak and new or larger related peaks, and LC-MS can show the mass shifts that point to a specific route, such as plus 16 Da for oxidation. Appearance alone is not a reliable guide.
- Lai MC, Topp EM, 1999. Solid-state chemical stability of proteins and peptides. Journal of Pharmaceutical Sciences, 88(5), 489 to 500. DOI
- Manning MC, Chou DK, Murphy BM, et al., 2010. Stability of Protein Pharmaceuticals: An Update. Pharmaceutical Research, 27(4), 544 to 575. DOI
- Geiger T, Clarke S, 1987. Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Journal of Biological Chemistry, 262(2), 785 to 794. DOI
- Wang W, 1999. Instability, stabilization, and formulation of liquid protein pharmaceuticals. International Journal of Pharmaceutics, 185(2), 129 to 188. DOI
- D’Hondt M, Bracke N, Taevernier L, et al., 2014. Related impurities in peptide medicines. Journal of Pharmaceutical and Biomedical Analysis, 101, 2 to 30. DOI
This article is general educational information about laboratory analysis and material handling. It is not medical, legal or regulatory advice, and nothing in it describes or recommends the use of any compound in people or animals. Materials supplied by Imperial Biolab are for research use only: not for human or veterinary use, not for diagnostic use, and not for use as a food, drug, dietary supplement or cosmetic. Sale is restricted to adults aged 21 or over. See the research use disclaimer for details.